Veracyte launches Prosigna breast cancer test in US market
Go back to Veracyte launches Prosigna breast cancer test in US market| VERACYTE (NASDAQ: VCYT) | Delayed: 52.61 -1.02 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.63 | 52 Week High | $8.45 | |||
| Open | $53.72 | 52 Week Low | $4.21 | |||
| Day High | $54.72 | P/E | N/A | |||
| Day Low | $52.36 | EPS | $-1.52 | |||
| Volume | 150,881 | |||||
